DK0833626T3 - Mono- og disulfosubstituerede anthraquioner og deres anvendelse til behandlingen af knoglematrixforstyrrelser - Google Patents
Mono- og disulfosubstituerede anthraquioner og deres anvendelse til behandlingen af knoglematrixforstyrrelserInfo
- Publication number
- DK0833626T3 DK0833626T3 DK96922001T DK96922001T DK0833626T3 DK 0833626 T3 DK0833626 T3 DK 0833626T3 DK 96922001 T DK96922001 T DK 96922001T DK 96922001 T DK96922001 T DK 96922001T DK 0833626 T3 DK0833626 T3 DK 0833626T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- bone matrix
- anthraquions
- disulfo
- mono
- Prior art date
Links
- 210000002805 bone matrix Anatomy 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003628 erosive effect Effects 0.000 abstract 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MI001357A IT1276781B1 (it) | 1995-06-23 | 1995-06-23 | Derivati antrachinonmono- e disolfon- sostituiti e composizioni farmaceutiche che li contengono per il trattamento delle patologie |
| PCT/EP1996/002597 WO1997000675A1 (en) | 1995-06-23 | 1996-06-17 | Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0833626T3 true DK0833626T3 (da) | 2003-06-30 |
Family
ID=11371864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96922001T DK0833626T3 (da) | 1995-06-23 | 1996-06-17 | Mono- og disulfosubstituerede anthraquioner og deres anvendelse til behandlingen af knoglematrixforstyrrelser |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5856358A (de) |
| EP (1) | EP0833626B1 (de) |
| JP (1) | JP3307650B2 (de) |
| AT (1) | ATE233553T1 (de) |
| AU (1) | AU6303996A (de) |
| CA (1) | CA2225277A1 (de) |
| CZ (1) | CZ293326B6 (de) |
| DE (1) | DE69626514T2 (de) |
| DK (1) | DK0833626T3 (de) |
| ES (1) | ES2193248T3 (de) |
| IT (1) | IT1276781B1 (de) |
| MX (1) | MX9800049A (de) |
| PT (1) | PT833626E (de) |
| RU (1) | RU2202534C2 (de) |
| SK (1) | SK281853B6 (de) |
| WO (1) | WO1997000675A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9608133D0 (en) * | 1996-04-19 | 1996-06-26 | Gemini International Holdings | Diagnostic method and apparatus |
| FR2757397B1 (fr) * | 1996-12-23 | 1999-03-05 | Mazal Pharma | Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree |
| JPH11236333A (ja) * | 1997-12-30 | 1999-08-31 | Pfizer Prod Inc | 抗ガン剤として有用なイミダゾリン−4−オン誘導体 |
| US6117869A (en) * | 1998-08-04 | 2000-09-12 | Warner-Lambert Company | Compounds for and methods of inhibiting matrix metalloproteinases |
| US6174903B1 (en) | 1998-12-28 | 2001-01-16 | Pfizer Inc. | Imidazolidin-4-one derivatives useful as anticancer agents |
| US6610750B1 (en) * | 2000-09-15 | 2003-08-26 | Laboratoires Negma | Treatment of osteoarthritis |
| AUPR229600A0 (en) * | 2000-12-22 | 2001-01-25 | Commonwealth Scientific And Industrial Research Organisation | New oxygen scavenging compositions |
| US6600057B2 (en) * | 2000-12-29 | 2003-07-29 | Kimberly-Clark Worldwide, Inc. | Matrix metalloproteinase inhibitors |
| EP2182810B1 (de) | 2007-08-03 | 2017-11-08 | Nucitec S.A. de C.V. | Zusammensetzungen und verfahren zur behandlung und prävention von osteoarthritis |
| JP2013512248A (ja) * | 2009-11-24 | 2013-04-11 | ジ・オハイオ・ステート・ユニバーシティ | 転写因子阻害剤および関連する組成物、製剤および方法 |
| EP2555618B1 (de) * | 2010-04-08 | 2015-12-30 | TWI Biotechnology, Inc. | Verfahren zur verwendung von diacerein als unterstützungstherapie für diabetes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2025954A (en) * | 1978-07-21 | 1980-01-30 | Ciba Geigy Ag | Anthraquinone Sulphonamides |
| IT1244773B (it) * | 1991-03-12 | 1994-08-08 | Gentili Ist Spa | N-(4,5-diidrossi-e 4,5,8-triidrossi-9,10-diidro-9,10-diosso-2- antracen-il)carbonil) amminoacidi utilizzabili nella terapia delle affezioni osteoarticolari |
-
1995
- 1995-06-23 IT IT95MI001357A patent/IT1276781B1/it active IP Right Grant
-
1996
- 1996-06-17 SK SK1760-97A patent/SK281853B6/sk unknown
- 1996-06-17 ES ES96922001T patent/ES2193248T3/es not_active Expired - Lifetime
- 1996-06-17 DK DK96922001T patent/DK0833626T3/da active
- 1996-06-17 WO PCT/EP1996/002597 patent/WO1997000675A1/en not_active Ceased
- 1996-06-17 CA CA002225277A patent/CA2225277A1/en not_active Abandoned
- 1996-06-17 JP JP50356397A patent/JP3307650B2/ja not_active Expired - Fee Related
- 1996-06-17 AU AU63039/96A patent/AU6303996A/en not_active Abandoned
- 1996-06-17 DE DE69626514T patent/DE69626514T2/de not_active Expired - Fee Related
- 1996-06-17 RU RU98101090/14A patent/RU2202534C2/ru not_active IP Right Cessation
- 1996-06-17 EP EP96922001A patent/EP0833626B1/de not_active Expired - Lifetime
- 1996-06-17 PT PT96922001T patent/PT833626E/pt unknown
- 1996-06-17 AT AT96922001T patent/ATE233553T1/de not_active IP Right Cessation
- 1996-06-17 US US08/981,287 patent/US5856358A/en not_active Expired - Fee Related
- 1996-06-17 CZ CZ19974193A patent/CZ293326B6/cs not_active IP Right Cessation
-
1998
- 1998-01-07 MX MX9800049A patent/MX9800049A/es not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP3307650B2 (ja) | 2002-07-24 |
| PT833626E (pt) | 2003-07-31 |
| RU2202534C2 (ru) | 2003-04-20 |
| SK176097A3 (en) | 1998-06-03 |
| MX9800049A (es) | 1998-11-30 |
| EP0833626A1 (de) | 1998-04-08 |
| CA2225277A1 (en) | 1997-01-09 |
| CZ419397A3 (cs) | 1998-07-15 |
| ITMI951357A0 (it) | 1995-06-23 |
| SK281853B6 (sk) | 2001-08-06 |
| ES2193248T3 (es) | 2003-11-01 |
| WO1997000675A1 (en) | 1997-01-09 |
| DE69626514T2 (de) | 2003-12-24 |
| CZ293326B6 (cs) | 2004-04-14 |
| US5856358A (en) | 1999-01-05 |
| DE69626514D1 (de) | 2003-04-10 |
| JPH11509186A (ja) | 1999-08-17 |
| IT1276781B1 (it) | 1997-11-03 |
| EP0833626B1 (de) | 2003-03-05 |
| AU6303996A (en) | 1997-01-22 |
| ITMI951357A1 (it) | 1996-12-23 |
| ATE233553T1 (de) | 2003-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971766D0 (no) | Anvendelsen av dioksomorfoliner for bekjempning av endoparasitter, nye dioksomorfoliner samt deres fremstilling | |
| ATE185797T1 (de) | Stilben-derivate verwendbar als cyclooxygenase-2 hemmer | |
| NO962286L (no) | N-substituerte azabicykloalkanderivater som neuroleptika etc. | |
| DE69505542D1 (de) | 3-benzoylbenzofuran-derivate als thyroidhormonantagonisten | |
| DE122005000055I2 (de) | Kristallines ceftiofur (freie säure) | |
| BR9509970A (pt) | Composto | |
| ATE233553T1 (de) | Mono-und disulfosubstituierte anthrachinone und deren verwendung zur behandlung von knochenmatrixerkrankungen | |
| DK0775143T3 (da) | 3-substituerede 3H-2,3-benzodiazepinderivater, deres fremstilling og anvendelse som lægdemidler | |
| DE59509186D1 (de) | N-substituierte azabicycloheptan-derivate als neuroleptika usw. | |
| ATE144497T1 (de) | N-substituierte 3-azabicyclo(3.2.0>heptan- derivate als neuroleptika | |
| DK0720598T3 (da) | Phenoxyphenylcyclopentenyl-hydroxyurinstoffer | |
| DK0668852T3 (da) | Substituerede orthoethenylphenyleddikesyrederivater | |
| DK0623118T3 (da) | Carbamatderivater og deres anvendelse i medicin | |
| DK0417875T3 (da) | 1-methoxypyrimidinyl-1H-1,2,4-triazol-3-sulfonsyrenitroanilider, fremgangsmåde til fremstilling heraf og deres anvendelse som middel med herbicid virkning |